Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane and coiled-coil domain family 1 pseudogene 1 (TMCC1P1) is classified as a pseudogene, meaning it is a segment of DNA resembling a functional gene but generally considered non-protein coding and nonfunctional in terms of producing proteins[3][4]. Pseudogenes like TMCC1P1 may arise from gene duplication or retrotransposition and often accumulate mutations that prevent their translation into functional proteins[1]. While some pseudogenes have regulatory roles, such as acting as competing endogenous RNAs or influencing gene expression, TMCC1P1 itself is not documented as a therapeutic target, receptor, enzyme, or transporter and is not implicated in direct biological functions, specific disease roles, or known drug interactions based on current publicly available annotations[3][4]. The entry is sometimes mistaken for a true gene or target due to its nomenclature, but its status as a pseudogene means it does not fit standard categories used for validated therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane and coiled-coil domain family 1 pseudogene 1 (TMCC1P1).